Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 5,860 shares at $36.15 ($212K) on 2024-02-22, disclosed to the SEC on 2024-02-23.
Open-market sale of $212k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.15 | 2,930 | $106K | 50.0% |
| 2 | $36.15 | 2,930 | $106K | 50.0% |
| Total | $36.15 avg | 5,860 | $212K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |